Daluyon, Jenmea A.

HRN: 26-78-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
CEFTRIAXONE 1G (VIAL)
03/15/2025
03/21/2025
IV
780mg
Q24
PCAP D
Waiting Final Action 
03/15/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/15/2025
03/21/2025
TOPICAL
100u
QID
Oral Thrush
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: